Hematology Oncology Associates of Illinois-Highland Park — Highland Park, Illinois

Hematology Oncology Associates of Illinois-Highland Park is a clinical research site located in Highland Park, Illinois, United States 60035.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Hematology Oncology Associates of Illinois-Highland Park has participated in 53 clinical trials with 21 currently active.

Therapeutic areas: Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology Oncology Associates of Illinois-Highland Park?

Hematology Oncology Associates of Illinois-Highland Park has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology Oncology Associates of Illinois-Highland Park conducted?

Hematology Oncology Associates of Illinois-Highland Park has 53 clinical trials on record, with 21 currently active. Their work covers Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Is Hematology Oncology Associates of Illinois-Highland Park accredited by Crixeo Health?

Hematology Oncology Associates of Illinois-Highland Park has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematology Oncology Associates of Illinois-Highland Park?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.